(Q35188388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Toxicity patterns of cytotoxic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Jean-Pierre Delord

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Pierre Canal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

141-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12889735%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1023565227808

6 November 2019

exact match

0 references

cites work

Predicting etoposide toxicity: relationship to organ function and protein binding

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of anticancer agents in pediatric patients (review).

1 reference

12 December 2020

Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.

1 reference

12 December 2020

Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer

1 reference

12 December 2020

Mitomycin C-induced renal toxicity, a dose-dependent side effect?

1 reference

12 December 2020

Oxaliplatin: a new therapeutic option in colorectal cancer

1 reference

12 December 2020

Modeling toxicity and response in carboplatin-based combination chemotherapy

1 reference

12 December 2020

Pharmacokinetic drug interactions of commonly used anticancer drugs.

1 reference

12 December 2020

Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience

1 reference

12 December 2020

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences

1 reference

12 December 2020

Phase I and pharmacologic study of topotecan in patients with impaired renal function

1 reference

12 December 2020

Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity

1 reference

12 December 2020

Clinical pharmacokinetics of commonly used anticancer drugs.

1 reference

12 December 2020

Pharmacodynamics in cancer therapy

1 reference

12 December 2020

Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patients

1 reference

12 December 2020

The myelotoxicity of carboplatin is influenced by the time of its administration

1 reference

12 December 2020

Clinical pharmacokinetics of epirubicin.

1 reference

12 December 2020

Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines

1 reference

12 December 2020

Chronopharmacokinetics of doxorubicin in patients with breast cancer

1 reference

12 December 2020

Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer

1 reference

12 December 2020

Clinical, pharmacokinetic and biological studies of topotecan.

1 reference

12 December 2020

Circadian rhythm of cell division.

1 reference

12 December 2020

Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion

1 reference

12 December 2020

Population pharmacokinetic model for topotecan derived from phase I clinical trials

1 reference

12 December 2020

The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil

1 reference

12 December 2020

Individual adaptive dosing of topotecan in ovarian cancer.

1 reference

12 December 2020

Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma

1 reference

12 December 2020

Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines

1 reference

12 December 2020

An overview of the clinical pharmacology of topotecan

1 reference

12 December 2020

Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan

1 reference

12 December 2020

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

12 December 2020

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study

1 reference

12 December 2020

Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations

1 reference

12 December 2020

Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide schedule.

1 reference

12 December 2020

Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer

1 reference

12 December 2020

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor

1 reference

12 December 2020

Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells

1 reference

12 December 2020

Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureas

1 reference

12 December 2020

An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia

1 reference

12 December 2020

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

12 December 2020

Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer.

1 reference

12 December 2020

Pharmacokinetic determinants of the activity and toxicity of antitumour agents

1 reference

12 December 2020

Five days of oral topotecan (Hycamtin), a phase I and pharmacological study in adult patients with solid tumours

1 reference

12 December 2020

Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma.

1 reference

12 December 2020

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

1 reference

12 December 2020

New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors

1 reference

12 December 2020

Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea

1 reference

12 December 2020

Oxaliplatin: pharmacokinetics and chronopharmacological aspects

1 reference

12 December 2020

Acute myelogenous leukemia after treatment for malignant germ cell tumors in children

1 reference

12 December 2020

Chemotherapy in elderly patients with colorectal cancer

1 reference

12 December 2020

Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy

1 reference

12 December 2020

Clinical pharmacokinetics of anti-metabolites.

1 reference

12 December 2020

O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan

1 reference

12 December 2020

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

1 reference

12 December 2020

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype

1 reference

12 December 2020

Toxicity of 5-fluorouracil.

1 reference

12 December 2020

Circadian timing of cancer chemotherapy

1 reference

12 December 2020

Cancer treatment and old people

1 reference

12 December 2020

1 reference

12 December 2020

Clinically relevant drug-drug interactions in oncology

1 reference

12 December 2020

Practical treatment guide for dose individualisation in cancer chemotherapy

1 reference

12 December 2020

Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene

1 reference

12 December 2020

The renal pathology in clinical trials of cis-platinum (II) diamminedichloride

1 reference

12 December 2020

A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer

1 reference

12 December 2020

Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.

1 reference

12 December 2020

Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods

1 reference

12 December 2020

In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.

1 reference

12 December 2020

Population pharmacokinetics of topotecan: intraindividual variability in total drug.

1 reference

12 December 2020

Implications of chronobiology for 5-fluorouracil (5-FU) efficacy

1 reference

12 December 2020